Literature DB >> 24777958

LXR-dependent and -independent effects of oxysterols on immunity and tumor growth.

Catia Traversari1, Silvano Sozzani, Knut R Steffensen, Vincenzo Russo.   

Abstract

Oxysterols are involved in maintaining cellular cholesterol levels. Recently, oxysterols have been demonstrated to modulate the function of immune cells and tumor growth. These effects can be dependent on the activation of the oxysterol-binding liver X receptors (LXRs) or, as recently demonstrated for T and B cells, DCs and neutrophils, can be independent of LXR activation. LXR-dependent oxysterol effects can be ascribed to the activation of LXRα, LXRβ or LXRαβ isoforms, which induces transcriptional activation or trans-repression of target genes. The prevalent activation of one isoform seems to be cell-, tissue-, or context-specific, as shown in some pathologic processes, i.e., infectious diseases, atherosclerosis, and autoimmunity. Oxysterol-LXR signaling has recently been shown to inhibit antitumor immune responses, as well as to modulate tumor cell growth. Here, we review the mechanisms that link oxysterols to tumor growth, and discuss possible networks at the basis of LXR-dependent and -independent oxysterol effects on immune cells and tumor development.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antitumor immune responses; Liver X receptor(s); Oxysterols

Mesh:

Substances:

Year:  2014        PMID: 24777958     DOI: 10.1002/eji.201344292

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

Review 2.  Lipid metabolism and lipophagy in cancer.

Authors:  Meenu Maan; Jeffrey M Peters; Mainak Dutta; Andrew D Patterson
Journal:  Biochem Biophys Res Commun       Date:  2018-02-10       Impact factor: 3.575

3.  Lipid Metabolism and Tumor Antigen Presentation.

Authors:  Hong Qin; Yaxi Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.

Authors:  Annette Graham; Anne-Marie Allen
Journal:  World J Cardiol       Date:  2015-05-26

5.  An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Authors:  Angelica Ortiz; Jun Gui; Farima Zahedi; Pengfei Yu; Christina Cho; Sabyasachi Bhattacharya; Christopher J Carbone; Qiujing Yu; Kanstantsin V Katlinski; Yuliya V Katlinskaya; Simran Handa; Victor Haas; Susan W Volk; Angela K Brice; Kim Wals; Nicholas J Matheson; Robin Antrobus; Sonja Ludwig; Theresa L Whiteside; Cindy Sander; Ahmad A Tarhini; John M Kirkwood; Paul J Lehner; Wei Guo; Hallgeir Rui; Andy J Minn; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2019-01-14       Impact factor: 31.743

Review 6.  Nuclear hormone receptors put immunity on sterols.

Authors:  Fabio R Santori
Journal:  Eur J Immunol       Date:  2015-08-27       Impact factor: 5.532

7.  24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.

Authors:  Matias Soncini; Gianfranca Corna; Marta Moresco; Nadia Coltella; Umberto Restuccia; Daniela Maggioni; Laura Raccosta; Chin-Yo Lin; Francesca Invernizzi; Roberto Crocchiolo; Claudio Doglioni; Catia Traversari; Angela Bachi; Rosa Bernardi; Claudio Bordignon; Jan-Åke Gustafsson; Vincenzo Russo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

Review 8.  Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration.

Authors:  Spyridon Theofilopoulos; Ernest Arenas
Journal:  F1000Prime Rep       Date:  2015-04-02

9.  Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases.

Authors:  Shan Yu; Sijia Li; Adam Henke; Evan D Muse; Bo Cheng; Gustav Welzel; Arnab K Chatterjee; Danling Wang; Jason Roland; Christopher K Glass; Matthew Tremblay
Journal:  FASEB J       Date:  2016-03-29       Impact factor: 5.191

Review 10.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

Authors:  Kush K Patel; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.